Viewing StudyNCT00315757

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 4:48 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00315757
Status: COMPLETED
Last Update Posted: 2013-08-08
First Post: 2006-04-17
Brief Title: Study of Mapatumumab in Combination With Bortezomib Velcade and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma
Sponsor: Human Genome Sciences Inc
Organization: Human Genome Sciences Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma
Keywords: